PACB 净利润历史(2016–2025)
Pacific Biosciences of California, Inc. (PACB) 年度净利润历史(来自 SEC 财报)—— 每个财年的申报值与同比变化。
-$546.4MFY2025 · FY2016 以来:-$74.4M → -$546.4M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | -$546.4M | -76.3% |
| FY2024 | -$309.9M | -1.0% |
| FY2023 | -$306.7M | +2.4% |
| FY2022 | -$314.2M | -73.4% |
| FY2021 | -$181.2M | -716.3% |
| FY2020 | $29.4M | +134.9% |
| FY2019 | -$84.1M | +18.0% |
| FY2018 | -$102.6M | -11.3% |
| FY2017 | -$92.2M | -24.0% |
| FY2016 | -$74.4M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议